Finance

Beta
Lists
TNDM:NASDAQ
Tandem Diabetes Care Inc
$19.12
+11.16%
(+1.92) 1D
$19.45
+1.73% (+0.33)
After hours
Closed: Jun 1, 4:00:00 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for TNDM...
Open
$19.47
High
$20.04
Low
$17.72
Mkt. cap
1.31B
Avg. vol.
2.62M
Volume
5.61M
52-wk high
$29.65
52-wk low
$9.98
EPS
-$1.40
Beta
1.64
Shares outstanding
68.53M
No. of employees
2K
Open
$19.47
High
$20.04
Low
$17.72
Mkt. cap
1.31B
Avg. vol.
2.62M
Volume
5.61M
52-wk high
$29.65
52-wk low
$9.98
EPS
-$1.40
Beta
1.64
Shares outstanding
68.53M
No. of employees
2K
News stories
From sources across the web
Profile
Tandem Diabetes Care, Inc. is an American medical device manufacturer based in San Diego, California. The company develops medical technologies for the treatment of diabetes and specifically insulin infusion therapy. Wikipedia
About Tandem Diabetes Care Inc
CEOJohn Sheridan
Employees2.5K
FoundedJan 2006
Headquarters-
SectorMedical device
Websitetandemdiabetes.com
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
240.68M
249.25M
290.38M
247.22M
Cost of goods sold
114.82M
114.96M
122.92M
110.43M
Cost of revenue
114.82M
114.96M
122.92M
110.43M
Research and development expenses
48.12M
47.92M
46.07M
46.04M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
109.60M
106.44M
113.10M
108.19M
Operating expense
157.71M
154.36M
159.17M
154.22M
Total operating expenses
272.54M
269.32M
282.09M
264.66M
Operating income
-31.86M
-20.06M
8.29M
-17.43M
Other non operating income
268.00K
9.00K
616.00K
26.00K
EBT including unusual items
-57.72M
-25.14M
4.68M
-19.88M
EBT excluding unusual items
-37.77M
-22.34M
4.68M
-19.88M
Income tax expense
-5.32M
-3.98M
5.27M
516.00K
Effective tax rate
9.22%
15.82%
112.58%
-2.60%
Other operating expenses
-
-
-
-
Net income
-52.40M
-21.16M
-589.00K
-20.39M
Net profit margin
-21.77%
-8.49%
-0.20%
-8.25%
Earnings per share
-0.48
-0.31
-0.01
-0.30
Interest and investment income
3.40M
3.20M
2.80M
3.60M
Interest expense
-1.90M
-2.06M
-2.08M
-2.20M
Net interest expenses
1.50M
1.14M
725.00K
1.40M
Depreciation and amortization charges
-
-
-
-
EBITDA
-27.49M
-15.57M
12.79M
-12.93M
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer